Research News

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

Knowing you have developed antibodies against the SARS-CoV-2 virus after recovering from COVID-19 doesn't tell you everything about your immunity. The levels and even types of antibodies can differ among patients, and those differences can influence whether a person is protected against being reinfected.

COVID-19 continues to wreak havoc globally, with over one million deaths to date. Yet what if an existing vaccine could make COVID-19 less deadly? A study just published put the theory to test, with promising results.

A recent study by scientists from University of Connecticut has revealed that the Ultra Violet (UV) light, in particular, is associated with decreased disease growth rate relative to other analyzed factors.

Marine Biotechnology Division of National Institute of Ocean Technology (NIOT) has discovered a potential anti-TB agent to fight against tuberculosis (TB) by successfully isolating the biomolecules of pharmacological importance from a marine microalgae Chlorella vulgaris.

Caption : A Purdue University team has developed a novel testing platform to evaluate how breast cancer cells respond to the recurrent stretching that occurs in the lungs during breathing.

Caption: Abnormal neurofibrillary tangles (NFTs) -- a buildup of tau protein in parts of the brain -- helped Edward Lee, MD, PhD, an assistant professor of Pathology and Laboratory Medicine, and other Penn Medicine scientists uncover this new form of dementia.